In an amicus brief filed with the United States Court of Appeals for the Federal Circuit regarding the ACLU-Myriad gene patenting case, James Watson argues that genes should not be patented. (Duke University's Center for Public Genomics has posted the brief here.) Watson writes that genes are a product of nature and encode "vital information" that directs whether a person is male or female, or blonde or brunette.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.